Human Milk Oligosaccharides and Infant Neurodevelopment: A Narrative Review
Nutrients · 31.01.2023 · 15 (3) · 719
DOI: 10.3390/nu15030719 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 31.01.2023. Verfasst von Paige K Berger und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Milk, Human, Infant, Premature. Die Arbeit wurde bisher 79-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NICHD NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
The objective of this narrative review was to synthesize the literature on human milk oligosaccharides (HMOs) and neurodevelopmental outcomes in human milk-fed infants. We conducted a scoping review of the literature indexed in PubMed reporting observational or interventional studies on HMO exposure in relation to psychometric measures in infants. Studies were characterized based on study design and definitions of HMO exposure and neurodevelopmental outcomes. Six studies were identified; all were observational in design, and five were conducted in full-term infants. Sample sizes ranged from 35–659 infants. HMOs were defined as individual concentrations or relative abundances assessed at 1 and/or 6 months of age. Studies accounted for differences in HMO exposure based on maternal secretor status. Neurodevelopmental outcomes were assessed between 6 and 24 months of age and included four domains. Studies in full-term infants reported that total and individual fucosylated and sialylated HMOs were positively associated with cognitive, language, and motor skill domains between 18 and 24 months of age, while the single study in preterm infants reported no statistically significant findings in the full cohort. The presence of a maternal secretor did not consistently alter the associations between HMO exposure and neurodevelopmental outcomes. Emerging evidence from observational studies suggests that HMO exposure may be beneficial for neurodevelopment in infants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Newborn Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Department of Pediatrics, Mother-Milk-Infant Center of Research Excellence (MOMI CORE), Human Milk Institute (HMI), University of California, La Jolla, CA 92093, USA.
ORCID-Profile: Paige K Berger, Mandy B Belfort
Förderung
- NCATS NIH HHS
- NICHD NIH HHS
- NIDDK NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Larsson-Rosenquist Foundation
- Academic Nutrition (Harvard T.H. Chan School of Public Health, Department of Nutrition)
- Harvard Catalyst|The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, National Institutes of Health)
- Harvard University and its affiliated academic healthcare centers
Zitieren
APA
Berger, P. K., Ong, M. L., Bode, L., & Belfort, M. B. (2023). Human Milk Oligosaccharides and Infant Neurodevelopment: A Narrative Review. Nutrients, 15(3), 719. https://doi.org/10.3390/nu15030719
Vancouver
Berger PK, Ong ML, Bode L, Belfort MB. Human Milk Oligosaccharides and Infant Neurodevelopment: A Narrative Review. Nutrients. 2023;15(3):719. doi:10.3390/nu15030719
BibTeX
@article{Berger2023,
author = {Berger, Paige K and Ong, Margaret L and Bode, Lars and Belfort, Mandy B},
title = {Human Milk Oligosaccharides and Infant Neurodevelopment: A Narrative Review},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {3},
pages = {719},
doi = {10.3390/nu15030719}
}
EUVIMED